Ennov is excited to announce our participation as a Bronze Sponsor in the upcoming Pronovea Pharma Summit 2024: Drug Safety and Risk Management. The summit is scheduled for April 24-25 at the Arcotel Wimberger Wien Hotel in Vienna and is dedicated to enhancing drug safety and risk management. It brings together pharmacovigilance pioneers and healthcare innovators to foster collaboration and advance the field.
At the Pronovea Pharma Summit, attendees will delve into the impact of Advanced Therapy Medicinal Products (ATMPs), the application of artificial intelligence, and global strategies for harmonizing safety protocols. Ennov’s Claudine Richon will be there to present a pivotal Pharmacovigilance Case Study.
Make sure to visit us at Booth #2, where you can learn more about Ennov’s cutting-edge Pharmacovigilance Suite. Our offerings aim to streamline and enhance the management of drug safety data, ensuring more effective risk management practices.
